Pluripotent Stem Cells in Eye Disease Therapy
This book discusses applications of pluripotent stem cells to study eye disease in vitro and to create novel therapies for degenerative eye diseases. Chapters are contributed by experts in the field and cover such topics as the use of pluripotent stem cel
- PDF / 4,483,135 Bytes
- 210 Pages / 439.42 x 683.15 pts Page_size
- 106 Downloads / 222 Views
Kapil Bharti Editor
Pluripotent Stem Cells in Eye Disease Therapy
Advances in Experimental Medicine and Biology Volume 1186
Editorial Board: IRUN R. COHEN, The Weizmann Institute of Science, Rehovot, Israel ABEL LAJTHA, N.S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA JOHN D. LAMBRIS, University of Pennsylvania, Philadelphia, PA, USA RODOLFO PAOLETTI, University of Milan, Milan, Italy NIMA REZAEI, Children’s Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran
More information about this series at http://www.springer.com/series/5584
Kapil Bharti Editor
Pluripotent Stem Cells in Eye Disease Therapy
Editor Kapil Bharti National Institutes of Health NEI Bethesda, MD, USA
ISSN 0065-2598 ISSN 2214-8019 (electronic) Advances in Experimental Medicine and Biology ISBN 978-3-030-28470-1 ISBN 978-3-030-28471-8 (eBook) https://doi.org/10.1007/978-3-030-28471-8 © Springer Nature Switzerland AG 2019 The Editor of this volume is participating in this project independently; neither he nor any of the views or data included in this book represent the NIH. This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Preface
Stem cells have an inherent ability to regenerate tissues and organs and because of this property they constitute the core of the field of regenerative medicine. However, stem cells alone are not sufficient to bring a regenerative medicine to patients. They must be combined with other areas of biology including but not limited to tissue engineering, bioengineering, drug discovery, immunology, and surgical approaches. I have focused this book on several of these aspects of regenerative medicine by presenting examples of various interdisciplina
Data Loading...
